Abs Novacell Biopharmaceuticals Private

Abs Novacell ABS Novacell is a Biopharmaceutical & Biotechnology company with the following Strategic Business Units: ? Novel Vaccines (Viral, Bacterial). ? Innovative Biotherapeutics & Biosimilars / Follow-On-Biologics. ? Biological Contract Manufacturing (Bio-CMO). ? Diagnostics. ABS Novacell is a subsidiary of American Biosources Inc., NJ, USA, ( Established in year 2001) having incubation centers at Buffalo, New York, Miami, Florida, USA and operational office in PA, USA. ABS Novacell is being promoted by world renowned scientists, business, Technology, Finance, Management team, The Board of Directors, Senior Management, Scientific and Technical advisory board consist of global leaders represents world class Biopharmaceutical companies and Academicians for the purpose of commercializing the established novel R&D pipeline products (new technology for manufacturing Swine Flu Vaccine, Seasonal Flu Vaccine, Bird Flu Vaccine and other Vaccines) with current Good Manufacturing Practices (cGMP) as per US-FDA, EU-EMEA, WHO and Indian Regulatory Standards (DCGI). ABS Novacell strongly believes in: ? Innovation and R & D ? Quality & Regulatory standards (ICH/US-FDA-EMEA) ? Taking advantage of Low cost and well spoken, Highly educated technical personnel. ABS Novacell want to leverage its Global Presence from United States of America and India. Our Management Team with solid Biopharmaceuticals / Vaccines / Biotechnology expertise bring immediate value to its Business bottom line, Partners, Stake-holders, Investors and Employees.